COVID-19: Weekly Summary (May 19-25, 2025)

Key trends, opinions and insights from personal blogs

A Week of COVID-19 Conversations

This week, the blogosphere was buzzing with discussions about COVID-19, and I’d say it was quite a mixed bag of insights and opinions. From the latest on vaccine strategies to the emergence of new variants, there’s a lot to unpack. Let’s dive into what caught my eye.

Vaccine Conversations and Controversies

One of the hot topics was the FDA's new approach to COVID vaccines. Jeremy Faust, MD shared an essay by Dr. Marty Makary and Dr. Vinay Prasad that stirred quite a bit of debate. They proposed a new vaccination strategy, but not everyone was on board. Concerns were raised about the omission of certain groups like pregnant women and young infants. There was also confusion about which conditions are considered high-risk. It feels like the conversation around vaccines is as complex as ever, with many voices weighing in on what should be prioritized.

Meanwhile, Naked Capitalism touched on the broader implications of the public’s mistrust in mRNA vaccines. The skepticism seems to be affecting the prospects of mRNA therapeutics for other diseases too. It’s a bit worrying to see how the scientific community’s reputation has taken a hit, and I wonder how this will play out in the long run.

The Human Toll of COVID-19

The human cost of the pandemic was another recurring theme. Scott Alexander highlighted the staggering number of 1.2 million American deaths due to COVID. It’s a sobering reminder of the pandemic’s impact, yet it seems like these numbers don’t always get the attention they deserve. Some commenters even challenged the accuracy of these figures, suggesting they might be inflated. But Scott presented evidence from census.gov and the CDC to back up his claims. It’s a bit of a reality check, and I’d say it’s worth pondering why these deaths aren’t more prominently discussed.

New Variants on the Horizon

On the topic of new COVID variants, Christina Pagel brought attention to NB.1.8.1 and XFG. These variants are spreading rapidly, and the World Health Organization has already flagged NB.1.8.1 as a 'variant under monitoring'. It’s a bit concerning, especially with the possibility of a summer wave in the UK and Europe. Christina pointed out that COVID isn’t just a winter virus, and its waves can be quite unpredictable. It makes me wonder how prepared we really are for these new challenges.

Political and Social Dimensions

The political and social dimensions of COVID-19 were also in the spotlight. Tom Knighton discussed how the Biden Administration labeled those opposing vaccination and mask mandates as “Domestic Violent Extremists.” It’s a pretty strong label, and it raises questions about how dissent is being handled in the current climate. It seems like the pandemic has not only been a health crisis but also a catalyst for political tensions.

Reflections and Personal Stories

Amidst all the heavy discussions, there were also personal reflections. Naeem Noor shared his experience of writing haikus during the pandemic. It’s a reminder of how people have turned to creative outlets to cope with the challenges of the past few years. The simplicity of a haiku, with its 5-7-5 syllable structure, seems to capture the essence of finding meaning in constraints.

A Broader Perspective

In the broader context, Naked Capitalism provided a collection of links covering a wide range of topics, including COVID-19. It’s interesting to see how the pandemic intersects with other global issues like climate change and international politics. It feels like COVID-19 is just one piece of a much larger puzzle that the world is trying to solve.

Wrapping Up

So, that’s a glimpse into the COVID-19 discussions from this week. There’s a lot more to explore, and I’d encourage you to check out the full posts from the authors for a deeper dive. Whether it’s the evolving vaccine strategies, the human toll, or the emergence of new variants, there’s no shortage of topics to ponder. It’s clear that the conversation around COVID-19 is far from over, and I’m curious to see where it goes next.